Synthetic peptides as valuable and versatile tools for research: our 20 year journey in Chile DOI Creative Commons
Constanza Cárdenas, Paula Santana, Claudio A. Álvarez

и другие.

Опубликована: Окт. 15, 2024

According to the International Union of Pure and Applied Chemistry (IUPAC), peptides are small proteins with a size between 2 50 amino acids residues. They ubiquitous across evolutionary scale, fulfilling wide variety functions, from immune system effectors in simple organisms signaling or neuromodulating agents high vertebrates. Following nature’s example, have emerged as alternatives various fields. One particularly relevant area is drug discovery, offering face emergence antibiotic-resistant microorganisms. Peptides also prevalent other sectors, such food industry, where they serve additives enhance nutritional characteristics aid preservation. Moreover, increasingly being utilized cosmetics. Additionally, valuable tools both basic applied research, facilitating exploration specific activity mechanisms verification particular activities, among applications. Despite certain limitations disadvantages compared bioactive molecules, remain focal point interest well developmental fields, due their versatility. In this report, we provide an overview extensive application landscape synthetic peptides, presenting examples developed in-house different areas which include summary methodologies results obtained.

Язык: Английский

Nanoassemblies designed for efficient nuclear targeting DOI Creative Commons
Michal Skowicki, Shabnam Tarvirdipour, Manuel Kraus

и другие.

Advanced Drug Delivery Reviews, Год журнала: 2024, Номер 211, С. 115354 - 115354

Опубликована: Июнь 12, 2024

One of the key aspects coping efficiently with complex pathological conditions is delivering desired therapeutic compounds precision in both space and time. Therefore, focus on nuclear-targeted delivery systems has emerged as a promising strategy high potential, particularly gene therapy cancer treatment. Here, we explore design supramolecular nanoassemblies vehicles to deliver specific nucleus, special polymer peptide-based carriers that expose nuclear localization signals. Such aim at maximizing concentration genetic agents within thereby optimizing treatment outcomes while minimizing off-target effects. A scenario conditions, including cellular uptake, endosomal escape, translocation, requires fine tuning nanocarriers' properties. First, introduce principles import role pore complexes reveal strategies for targeting nanosystems nucleus. Then, provide an overview cargoes rely optimal activity their integrity accumulation are crucial parameters consider when designing suitable system. Considering they early stages research, present various cargo-loaded peptide- promote targeting, emphasizing potential enhance response. Finally, briefly discuss further advancements more precise effective delivery.

Язык: Английский

Процитировано

7

Peptide-Functionalized Lipid Nanoparticles for Targeted Systemic mRNA Delivery to the Brain DOI
Emily L. Han, Sophia Tang, Dongyoon Kim

и другие.

Nano Letters, Год журнала: 2024, Номер unknown

Опубликована: Дек. 17, 2024

Systemic delivery of large nucleic acids, such as mRNA, to the brain remains challenging in part due blood-brain barrier (BBB) and tendency vehicles accumulate liver. Here, we design a peptide-functionalized lipid nanoparticle (LNP) platform for targeted mRNA brain. We utilize click chemistry functionalize LNPs with peptides that target receptors overexpressed on endothelial cells neurons, namely RVG29, T7, AP2, mApoE peptides. evaluate effect LNP targeting neuronal cell transfection vitro, investigating factors serum protein adsorption, intracellular trafficking, transcytosis, exosome secretion. Finally, show peptide functionalization enhances mouse reduces hepatic after systemic administration. Specifically, RVG29 improved vivo, establishing its potential nonviral delivering

Язык: Английский

Процитировано

6

Straight to the point: targeted mRNA-delivery to immune cells for improved vaccine design DOI Creative Commons

Bruna Clemente,

Maxime Denis, Camila P. Silveira

и другие.

Frontiers in Immunology, Год журнала: 2023, Номер 14

Опубликована: Ноя. 27, 2023

With the deepening of our understanding adaptive immunity at cellular and molecular level, targeting antigens directly to immune cells has proven be a successful strategy develop innovative potent vaccines. Indeed, it offers potential increase vaccine potency and/or modulate response quality while reducing off-target effects. mRNA-vaccines establishing themselves as versatile technology for future applications, in last years several approaches have been explored target nanoparticles-enabled mRNA-delivery systems cells, with focus on dendritic cells. Dendritic (DCs) are most antigen presenting key mediators B- T-cell immunity, therefore considered an ideal cell-specific delivery. improved DC-targeted vaccines proved vitro vivo . This review discusses specific targets system-directed mRNA delivery, well different ligand classes delivery used this purpose.

Язык: Английский

Процитировано

16

Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment DOI Creative Commons
Weranga Rajapaksha, Riya Khetan, I. R. Johnson

и другие.

Frontiers in Drug Delivery, Год журнала: 2024, Номер 4

Опубликована: Фев. 1, 2024

Ovarian cancers are a complex and heterogenic group of malignancies that difficult to detect, diagnose treat. Fortunately, considerable knowledge ovarian cancer specific biomarkers has been generated, is pertinent the development novel theranostic platforms by combining therapies diagnostics. Genomic proteomic data invaluable in providing critical biomolecular targets for approaches. Exploitation wealth biomarker research conducted offers viable as beacons detection, diagnosis, therapeutic targeting. These markers can be used theranostics, treatment strategy combines therapy diagnostics common nuclear medicine, where radionuclides both diagnosis treatment. The theranostics taken substantial focus recent years battle against cancer. Yet date only one technology emerged clinical practice. However, given field poised see emergence revolutionary disease monitoring outcomes through their incorporation into strategies. future set enable precise targeted treatment, vigilant monitoring. This review aims assess status diagnostic tools practice, development, or pre-clinical highlighting newly emerging applications.

Язык: Английский

Процитировано

5

Applications of peptides in nanosystems for diagnosing and managing bacterial sepsis DOI Creative Commons
Mohammed A. Gafar, Calvin A. Omolo, Eman Elhassan

и другие.

Journal of Biomedical Science, Год журнала: 2024, Номер 31(1)

Опубликована: Апрель 19, 2024

Abstract Sepsis represents a critical medical condition stemming from an imbalanced host immune response to infections, which is linked significant burden of disease. Despite substantial efforts in laboratory and clinical research, sepsis remains prominent contributor mortality worldwide. Nanotechnology presents innovative opportunities for the advancement diagnosis treatment. Due their unique properties, including diversity, ease synthesis, biocompatibility, high specificity, excellent pharmacological efficacy, peptides hold great potential as part nanotechnology approaches against sepsis. Herein, we present comprehensive up-to-date review applications nanosystems combating sepsis, with expedite enhance management outcomes. Firstly, pathophysiology, antisepsis drug targets, current modalities limitations, advance have been adequately addressed. The organized into diagnostic or managing applications, last one being further sub-organized nano-delivered bioactive antimicrobial anti-inflammatory activity, targeting moieties on surface nanocarriers agents. studies grouped thematically discussed, emphasizing constructed nanosystem, physicochemical peptide-imparted enhancement therapeutic efficacy. strengths, research gaps each section elaborated. Finally, challenges future paths use deliberately spotlighted. This reaffirms peptides' promising biomaterials within strategies aimed at improving management. Graphical

Язык: Английский

Процитировано

4

Anti-angiogenic biomolecules in neovascular age-related macular degeneration; therapeutics and drug delivery systems DOI

Mir Salar Kazemi,

Alireza Shoari,

Neda Salehibakhsh

и другие.

International Journal of Pharmaceutics, Год журнала: 2024, Номер 659, С. 124258 - 124258

Опубликована: Май 22, 2024

Язык: Английский

Процитировано

4

Design and applications of polymer-like peptides in biomedical nanogels DOI

Iordana Neamţu,

Alina Ghilan,

Alina Gabriela Rusu

и другие.

Expert Opinion on Drug Delivery, Год журнала: 2024, Номер 21(5), С. 713 - 734

Опубликована: Май 3, 2024

Introduction Polymer nanogels are among the most promising nanoplatforms for use in biomedical applications. The substantial interest these drug carriers is to enhance transportation of bioactive substances, reduce side effects, and achieve optimal action on curative sites by targeting delivery triggering release drugs a controlled continuous mode.

Язык: Английский

Процитировано

4

Surface modified proteins and peptides for targeted drug delivery DOI
Vivek P. Chavda, Disha Joshi

Progress in molecular biology and translational science, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Unlocking the secrets of the immunopeptidome: MHC molecules, ncRNA peptides, and vesicles in immune response DOI Creative Commons
Arpita Balakrishnan,

Gabriela Winiarek,

Olga Hołówka

и другие.

Frontiers in Immunology, Год журнала: 2025, Номер 16

Опубликована: Янв. 29, 2025

The immunopeptidome, a diverse set of peptides presented by Major Histocompatibility Complex (MHC) molecules, is critical component immune recognition and response. This review article delves into the mechanisms peptide presentation MHC particularly emphasizing roles ncRNA-derived extracellular vesicles (EVs) in shaping immunopeptidome landscape. We explore established emerging insights molecule interactions with peptides, including dynamics loading, transport, influence cellular genetic variations. highlights novel research on non-coding RNA (ncRNA)-derived which challenge conventional views antigen processing role EVs transporting these thereby modulating responses at remote body sites. not only challenges but also opens up new avenues for understanding responses. Furthermore, we discuss implications developing therapeutic strategies, cancer immunotherapy. By conducting comprehensive analysis current literature advanced methodologies immunopeptidomics, this aims to deepen complex interplay between system, offering perspectives potential diagnostic applications. Additionally, provide mechanism enhanced surface highlight pathway their systemic distribution, potentially altering surveillance landscapes.

Язык: Английский

Процитировано

0

Peptide-driven strategies against lung cancer DOI

Vijayshree S Karankar,

Saurabh Awasthi, Nidhi Srivastava

и другие.

Life Sciences, Год журнала: 2025, Номер unknown, С. 123453 - 123453

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0